⌘K
t
| Date | 30 Sept 2024 |
| Time | 14:03:25 |
| Category | Miscellaneous |
| ID | 2865G |
30 September 2024
ProBiotix Health plc
("ProBiotix" or the "Company" or, together with its subsidiary, the "Group")
Total Voting Rights
ProBiotix Health plc (AQSE: PBX), the life sciences business developing probiotics to support cardiometabolic health, announces that the Company has 158,166,666 ordinary shares of 0.05p each in issue ("Ordinary Shares"), each share carrying the right to one vote.
This figure of 158,166,666 Ordinary Shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.
For further information, please contact:
|
ProBiotix Health plc |
|
|
Steen Andersen, Chief Executive Officer |
|
|
|
|
|
Peterhouse Capital Limited Aquis Corporate Adviser And Broker |
Tel: 020 7220 9793 |
|
Mark Anwyl
|
|
|
Walbrook PR Ltd Anna Dunphy
|
Mob: 07876 741 001
|